ADVANCED MALIGNANT SOLID TUMOR
Clinical trials for ADVANCED MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody drug targets Hard-to-Treat cancers in early trial
Disease control OngoingThis study tests a drug called PRL3-zumab in 60 adults with advanced solid tumors that have not responded to standard treatments. The drug is given by IV every two weeks and aims to slow or stop tumor growth by targeting a protein found in many cancers. Researchers will monitor s…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New cancer drug BNT314 enters first human safety trial
Disease control OngoingThis study is the first to test BNT314 in humans. It aims to see if the drug is safe when given alone to people with advanced solid tumors that have not responded to other treatments. About 41 participants will receive different doses to find the highest dose that is still safe a…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 22, 2026 13:54 UTC